期刊文献+

喉癌及癌旁组织CD95、CD95L的表达及意义

Expressions and significance of CD95 and CD95L in laryngiocarcinomas and side tissue of cancer
下载PDF
导出
摘要 目的 :研究喉癌组织及癌旁组织CD95、CD95L的表达 ,了解喉癌细胞的生物学特性 ,指导临床治疗。方法 :取 2 3例喉癌手术患者的喉癌组织及癌旁组织 ,用免疫组化法确定CD95、CD95L的分布及强度。结果 :喉癌组织及癌旁组织的Fas ,FasL均有不同程度的表达。Fas的表达在喉癌组织为 5 2 .17% ,癌旁组织为 73.91% (P <0 .0 5 )。喉癌组织与癌旁组织比较明显地呈低表达。FasL表达在喉癌组织为 82 .6 1% ,癌旁组织为 5 6 .5 2 % (P <0 .0 5 ) ,喉癌组织与癌旁组织比较明显地呈高表达。结论 :Fas ,FasL在喉癌的细胞凋亡调节过程中具有重要作用。肿瘤细胞FasL高表达有利于肿瘤细胞逃逸机体的免疫监视。癌旁 Objective: To determine the expression of CD95 and CD95L in laryngiocarcinomas and side tissue of cancer,so as to direct surgic al treatment. Method: CD95 and CD95L were investigated by immunohistochemistry in surgical samples collected from 23 patients of laryngiocarcinomas.Results: There were the expression of CD95 and CD95L in both laryngic carcinoma cell and side tissue of cancer. The expression rate of CD95 was 52.17% in carcinoma cells, 73.91% in side tissue of cancer. The expression rate of CD95L was 82.16% in carcinoma cells, 56.52% in side tissue of cancer. The expression of CD95 in carcinoma cells was significantly lower than that in side tissue of cancer(P<0.05). The expression rate of CD95L was significantly higher in carcinoma cells than that in side tissue of cancer(P<0.05). Conclusion: These findings suggest that CD95,CD95L system active in laryngiocarcinoms apoptosis. Laryngiocarcinoma cells with higher expression of CD95L will be help for escaped surveillance by immunity system. Side tissue(2mm) of cancer may be intruded by cancer cells.
出处 《山东大学基础医学院学报》 2004年第6期348-350,共3页 Journal of Preclinical Medicine College of Shandong Medical University
基金 广东省科学技术委员会科研基金资助课题 (c30 90 2 )
关键词 喉肿瘤 抗原 CD95 细胞凋亡 Laryngeal neoplasms Antiges, CD95 Apoptosis
  • 相关文献

参考文献8

  • 1Nagata S,Golsterin P.The Fas death factor[J].Scince,1995,167:1449-1451. 被引量:1
  • 2Murak Y,Yashioka C,Fukuda J,et al.Localization of Fas antigen in oral squamous cell carcinoma[J].Br J Oral Maxillofacial Surg,1999,37:37-40. 被引量:1
  • 3Gastman BR,Atarshi Y,Reichert TE,et al.Fas ligandis expressed on human squamous cell carcinomas of the head and neck,and it promots apoptosis of T lymphocytes[J].Cancer Res,1999,59:5356-5364. 被引量:1
  • 4Riedel F,Gotte K,Bergler W,et al.Inverse correlation of apoptotic and angiogenic markers in squamous cell carcinoma of the head and neck[J].Oncol Rep,2001,8(3):471-476. 被引量:1
  • 5Lang S,Atarashi Y,Nishioka Y,et al.B7.1 on human carcinomas:costimulation of T cells and enhanced tumor-induced T-cell death[J].Cell Immunol,2000,201(2):132-143. 被引量:1
  • 6Hoffmann TK,Dworacki G,Tsukihiro T,et al.Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance[J].Clin Cancer Res.2002,8(8):2553-2562. 被引量:1
  • 7Whiteside TL,Rabinowich H.The role of Fas/FasL in immunosuppression induced by humman tumor[J].Cancer Immunology,1998,46(4):175-184. 被引量:1
  • 8张天振,董频,栾信庸,张庆泉.Fas,FasL在喉癌中的表达及其临床意义[J].山东大学基础医学院学报,2003,17(3):160-162. 被引量:3

二级参考文献10

  • 1Suda T, Takahashi T, Golstein P, et al. Molecular cloning and expressit on of the Fas ligand, a novel member of the tumor necrosis factor family [J]. Ce11,1993,75:1169- 1178. 被引量:1
  • 2Bennett MW, O'connell J, O'sullivan GC, et al. The Fas counterattack in vivo: apoptotic depletion of tumor- infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma[ J]. J Immunol, 1998, 160( 11 ):5669- 5675. 被引量:1
  • 3Trauth BC, Klas C, Peters AM J, et al. Monoclonal antibody mediated tumor regression by induction of apoptosis[ J ]. Science, 1989,245:301 - 305. 被引量:1
  • 4Yonehava S, Ishii A, Yonehara M .A cell killing monoclonal antibody (anti - Fas) to a cell surface antigen co - down regulated with the receptor of tumor necrosis factor [ J]. J Exp Med, 1989,169:1747- 1756. 被引量:1
  • 5Leithauser F, Dhein J, Mechtersheimer G, et al. Constitutive and induced expression of Apo - 1, a new member of the nerve growth factor / tumor necros is factor receptor superfamily, in normal and neoplastic cells [J]. Lab Invest, 1993,6 9(4):415 -429. 被引量:1
  • 6Rensing- Ehl A, Frei K, Flury R, et al. Local Fas/Apo- 1 (CD95) ligand - mediated tumor cell killing in vivo [J]. Eur J Immunol, 1995,25:2253 - 2258. 被引量:1
  • 7O'connell J, Benett JM, O'sullivan C, et al. The Fas counterattack: a molecular mechanism of tumor immune privilege [J]. Mol Med, 1997,3:294. 被引量:1
  • 8宋建勋.Fas抗原表位与死亡信号传导的关系[J].免疫学杂志,1997,13(3):206-207. 被引量:6
  • 9孙长凯,鞠躬.FasL-Fas/APO-1(CD95)系统[J].生理科学进展,1997,28(2):136-138. 被引量:17
  • 10肖冰,时永全,赵燕秋,尤涵,刘宪玲,樊代明.Fas基因转导胃癌细胞的表达[J].华人消化杂志,1998,6(5):400-403. 被引量:7

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部